Serum HE4: An Independent Prognostic Factor in Non-Small Cell Lung Cancer

Open Access

Peer-reviewed

Research Article

Pierre-Jean Lamy ,

* E-mail: pierre-jean.lamy@labosud-ocbiologie.fr

Affiliations Department of Biology and Oncogenetics, Montpellier Cancer Institute, Montpellier, France, ICM-Biobank, Regional Cancer Center, Montpellier, France
⨯
Carine Plassot,

Affiliation Department of Statistics and Epidemiology, Institute for Clinical Research, University Montpellier I, Montpellier, France
⨯
Jean-Louis Pujol

Affiliation Thoracic Oncology Unit, Hospital University Center of Montpellier, Montpellier France
⨯

Reader Comments (0)

Non-small cell lung cancer
Is the Subject Area "Non-small cell lung cancer" applicable to this article?

Thanks for your feedback.
Ovarian cancer
Is the Subject Area "Ovarian cancer" applicable to this article?

Thanks for your feedback.
Adenocarcinoma
Is the Subject Area "Adenocarcinoma" applicable to this article?

Thanks for your feedback.
Adenocarcinoma of the lung
Is the Subject Area "Adenocarcinoma of the lung" applicable to this article?

Thanks for your feedback.
Metastasis
Is the Subject Area "Metastasis" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Lung and intrathoracic tumors
Is the Subject Area "Lung and intrathoracic tumors" applicable to this article?

Thanks for your feedback.
Histology
Is the Subject Area "Histology" applicable to this article?

Thanks for your feedback.